F11a and FX12a Inhibitors – the Next Wave of Novel Anticoagulants?
Anticoagulation treatment has been revolutionised in the past few decades with the development of drugs that increasingly target individual components of the coagulation cascade. Yet the quest to find improved […]
Time is Right for Restrictive Transfusion Strategy in ECMO
Despite studies supporting a restrictive red cell transfusion strategy in many medical situations, a more liberal strategy is still widely used in patients who need extracorporeal membrane oxygenation (ECMO), Alexander […]